Literature DB >> 7472787

Factors associated with length of survival among 1081 terminally ill cancer patients.

P Allard1, A Dionne, D Potvin.   

Abstract

To improve their ability to estimate the survival of terminally ill cancer patients, palliative care physicians require accurate information on prognostic factors. The objective of this study was to assess the extent to which variables such as patient characteristics and primary tumor site affect the length of survival of terminally ill cancer patients. The study population consisted of 1081 cancer patients admitted for terminal care to a 15-bed palliative care unit from 1985 to 1991. Univariate Kaplan-Meier survival analysis and multivariate Cox regression analyses were used to examine the relationship between patient characteristics at admission and survival time. The factor most strongly associated with shorter survival was poor performance status; this strong relationship was not altered by taking into account sex and primary cancer site in the multivariate analysis. For patients who were bedridden at admission, the death rate was 5.5 times higher (95% confidence interval (Cl) 3.4-9.0) than that for ambulatory patients during the first four days of stay, and it was 2.8 times higher (95% Cl 2.0-3.9) subsequently (up to 19 days). The other prognostic factors significantly but slightly associated with poorer survival in the univariate analysis were primary lung cancer, male sex, and living with a spouse. These findings indicate that performance status is the main prognostic factor for accurately estimating the survival time of terminally ill cancer patients.

Entities:  

Mesh:

Year:  1995        PMID: 7472787

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  8 in total

1.  Appropriate time frames for data collection in quality of life research among cancer patients at the end of life.

Authors:  Siew Tzuh Tang; Ruth McCorkle
Journal:  Qual Life Res       Date:  2002-03       Impact factor: 4.147

2.  Predictors of home care expenditures and death at home for cancer patients in an integrated comprehensive palliative home care pilot program.

Authors:  Doris M Howell; Tom Abernathy; Rhonda Cockerill; Kevin Brazil; Frank Wagner; Larry Librach
Journal:  Healthc Policy       Date:  2011-02

3.  Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process.

Authors:  Erin F Gillespie; Noah J Mathis; Max Vaynrub; Ernesto Santos Martin; Rupesh Kotecha; Joseph Panoff; Andrew L Salner; Alyson F McIntosh; Ranju Gupta; Amitabh Gulati; Divya Yerramilli; Amy J Xu; Meredith Bartelstein; David M Guttmann; Yoshiya J Yamada; Diana Lin; Kaitlyn Lapen; Deborah Korenstein; David G Pfister; Allison Lipitz-Snyderman; Jonathan T Yang
Journal:  Clin Transl Radiat Oncol       Date:  2022-04-26

4.  Descriptive analysis of clinical factors affecting terminally ill cancer patients.

Authors:  A M Jiménez-Gordo; J Feliu; B Martínez; J de-Castro; N Rodríguez-Salas; N Sastre; Y Vilches; E Espinosa; J R Rodríguez-Aizcorbe; M González-Barón
Journal:  Support Care Cancer       Date:  2008-06-05       Impact factor: 3.603

5.  Predicting survival time in noncurative patients with advanced cancer: a prospective study in China.

Authors:  Jing Cui; Lingjun Zhou; B Wee; Fengping Shen; Xiuqiang Ma; Jijun Zhao
Journal:  J Palliat Med       Date:  2014-04-07       Impact factor: 2.947

6.  Identifying potential need for cancer palliation in Nova Scotia.

Authors:  G M Johnston; L Gibbons; F I Burge; R A Dewar; I Cummings; I G Levy
Journal:  CMAJ       Date:  1998-06-30       Impact factor: 8.262

Review 7.  Optimal Supportive Care for Patients With Metastatic Breast Cancer According to Their Disease Progression Phase.

Authors:  Kumiko Kida; Ian Olver; Sriram Yennu; Debu Tripathy; Naoto T Ueno
Journal:  JCO Oncol Pract       Date:  2021-01-22

8.  Treatment Patterns Among De Novo Metastatic Cancer Patients Who Died Within 1 Month of Diagnosis.

Authors:  Helmneh M Sineshaw; Ahmedin Jemal; Kimmie Ng; Raymond U Osarogiagbon; K Robin Yabroff; Kathryn J Ruddy; Rachel A Freedman
Journal:  JNCI Cancer Spectr       Date:  2019-04-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.